The patient perspective in the era of personalized medicine: What about scanxiety?

Custers, JAE; Davis, L; Messiou, C; Prins, JB; van der Graaf, WTA

dc.contributor.author	Custers, JAE
dc.contributor.author	Davis, L
dc.contributor.author	Messiou, C
dc.contributor.author	Prins, JB
dc.contributor.author	van der Graaf, WTA
dc.date.accessioned	2021-07-02T11:24:19Z
dc.date.available	2021-07-02T11:24:19Z
dc.identifier.citation	Cancer medicine, 2021, 10 (9), pp. 2943 - 2945
dc.identifier.issn	2045-7634
dc.identifier.uri	https://repository.icr.ac.uk/handle/internal/4670
dc.identifier.eissn	2045-7634
dc.identifier.doi	10.1002/cam4.3889
dc.description.abstract	Frequency of scanning has accelerated in the era of personalized medicine and is related, but not restricted, to the exploding number of clinical trials for new cancer treatments. Particularly in drug trials, but also in clinical practice, patients are followed up by scans frequently, which may vary from every 6 to 12 weeks until progression. The authors aimed to raise awareness for this underreported but widely present "Sword of Damocles" scan-related issue also referred to as 'scanxiety.'
dc.format	Print-Electronic
dc.format.extent	2943 - 2945
dc.language	eng
dc.language.iso	eng
dc.rights.uri	https://creativecommons.org/licenses/by/4.0
dc.title	The patient perspective in the era of personalized medicine: What about scanxiety?
dc.type	Journal Article
dcterms.dateAccepted	2021-05-01
rioxxterms.version	VoR
rioxxterms.versionofrecord	10.1002/cam4.3889
rioxxterms.licenseref.uri	https://creativecommons.org/licenses/by/4.0
rioxxterms.type	Journal Article/Review
dc.relation.isPartOf	Cancer medicine
pubs.issue	9
pubs.notes	Not known
pubs.organisational-group	/ICR
pubs.organisational-group	/ICR
pubs.publication-status	Published
pubs.volume	10
pubs.embargo.terms	Not known
dc.contributor.icrauthor	Messiou, Christina